跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,590 条关于
“muscarinic M3 receptors”
全部
5,590
临床试验
3,462
药物
644
机构
9
资讯
1,475
去年
Zydus Healthcare Secures CDSCO Approval for Phase III Trials of Two COPD Combination Therapies
去年
Zydus Healthcare to Conduct Phase III Trial for Glycopyrrolate/Indacaterol Inhaler
去年
FDA Approves Cobenfy, a Novel Muscarinic Receptor-Targeting Drug for Schizophrenia
去年
Cobenfy Approved for Schizophrenia: A Novel Muscarinic Receptor Agonist
9个月前
FDA Approves Edwards' Sapien M3 as First Transseptal Mitral Valve Replacement System
10个月前
Neumora Therapeutics Initiates Phase 1 Trial for Second M4 Muscarinic Receptor Modulator NMRA-898
去年
Neurocrine Biosciences Advances Novel Muscarinic M4 Agonist to Phase 3 Trials for Schizophrenia
去年
AbbVie's Emraclidine Fails in Schizophrenia Trials, Jolting Muscarinic Antipsychotic Development
去年
Cipla Advances Inhaled Antifungal Therapy with Phase III Trial Approval for Itraconazole Dry Powder
去年
Schizophrenia Treatment Targeting Cholinergic Receptors Receives FDA Approval
第 1 页,共 148 页
上一页
下一页